Adial Pharmaceuticals, Inc.
ADIL
$6.45
-$0.20-3.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -57.80M | -7.77M | -7.98M | -8.05M | -8.45M |
| Total Depreciation and Amortization | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.11M | 984.80K | 1.02M | 1.06M | 1.06M |
| Change in Net Operating Assets | -437.10K | 266.50K | 465.90K | 368.70K | 911.10K |
| Cash from Operations | -11.13M | -6.52M | -6.49M | -6.62M | -6.48M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 5.28M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 150.00K | 150.00K | 150.00K |
| Cash from Investing | 5.28M | 0.00 | 150.00K | 150.00K | 150.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.29M | 8.74M | 8.47M | 5.87M | 8.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 24.36M | -- | -- | -- | -- |
| Cash from Financing | 28.65M | 8.74M | 8.47M | 5.87M | 8.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.80M | 2.22M | 2.13M | -598.50K | 2.63M |